SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,649,000 | +25.7% | 27,559 | -3.8% | 0.05% | +21.4% |
| Q1 2018 | $1,312,000 | +21.7% | 28,641 | +5.9% | 0.04% | +20.0% |
| Q4 2017 | $1,078,000 | +1.5% | 27,054 | +1.9% | 0.04% | -7.9% |
| Q3 2017 | $1,062,000 | -17.4% | 26,550 | -11.0% | 0.04% | -24.0% |
| Q2 2017 | $1,285,000 | +17.5% | 29,825 | -14.6% | 0.05% | +11.1% |
| Q1 2017 | $1,094,000 | +10.4% | 34,940 | -11.0% | 0.04% | 0.0% |
| Q4 2016 | $991,000 | -13.1% | 39,247 | -14.9% | 0.04% | -18.2% |
| Q3 2016 | $1,140,000 | +5.9% | 46,105 | -12.8% | 0.06% | -3.5% |
| Q2 2016 | $1,076,000 | +36.7% | 52,844 | +2.5% | 0.06% | +26.7% |
| Q1 2016 | $787,000 | – | 51,580 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 699,432 | $35,216,000 | 4.25% |
| Provident Investment Management, Inc. | 590,269 | $29,720,000 | 4.23% |
| CAPITAL MANAGEMENT CORP /VA | 225,232 | $11,340,000 | 2.90% |
| FALCON POINT CAPITAL, LLC | 188,341 | $9,483,000 | 2.04% |
| Ranger Investment Management | 600,464 | $30,233,000 | 2.00% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 471,260 | $23,728,000 | 1.96% |
| KOPP INVESTMENT ADVISORS LLC | 41,700 | $2,100,000 | 1.77% |
| SHAKER INVESTMENTS LLC/OH | 49,617 | $2,498,000 | 1.54% |
| Bruce & Co., Inc. | 148,058 | $7,454,000 | 1.44% |
| Bridge City Capital, LLC | 45,843 | $2,308,000 | 1.43% |